Christopher Chang MD

Christopher Chang, MD, PhD, is a Professor at the University of New Mexico and the New Mexico VA Health Care System. As a physician-scientist, his long-term research and clinical interests center on gut microbes and their role in GI health and disease.

Dr. Chang’s clinic provides diagnostic and treatment options for patients who suffer from sequelae of GI infection, such as irritable bowel syndrome (IBS) and small intestinal bacterial overgrowth, as well as other gut motility disorders. He is Board certified in internal medicine and gastroenterology, Dr. Chang has been awarded investigative grants from the National Institute of Health and the American Gastroenterological Association. His research has focused on mechanisms of gut microbial pathogenesis and the impact of intestinal bacterial on immune responses, gut motility and other physiological processes. Most recently, he developed and is characterizing an animal model for post-infectious IBS to better understand the pathogenesis of IBS and identify therapeutic targets.

Dr. Chang has authored peer-reviewed research articles in numerous basic science and clinical investigative journals, and reviewed papers for the Journal of Bacteriology, Infection and Immunity, The IBD Journal, and other publications. He is a member of several scientific and professional organizations including the American Society for Microbiology, the American Gastroenterological Association, and the American College of Gastroenterology.